​
Login / Signup
S Yu Serebrova
ResearcherID
ResearcherID
ORCID
Publication Activity (10 Years)
Years Active: 2020-2022
Publications (10 Years): 6
Top Topics
Highly Efficient
Randomized Controlled Trial
Brain Injury
Bacillus Subtilis
Top Venues
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Voprosy pitaniia
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
M V Zhuravleva
,
P R Kamchatnov
,
N S Vasyukova
,
V V Arkhipov
,
E V Kuznetsova
,
T R Kameneva
,
S Yu Serebrova
[Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
122 (11) (2022)
M V Zhuravleva
,
I A Shchukin
,
M S Fidler
,
A B Prokofiev
,
S Yu Serebrova
,
N S Vasyukova
,
E Yu Demchenkova
,
V V Arkhipov
[Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
120 (12. Vyp. 2) (2021)
M V Zhuravleva
,
M V Davydovskaya
,
E V Luchinina
,
T V Shelekhova
,
D O Kurguzova
,
S Yu Serebrova
[Comparison of the clinical benefits of second-line drugs modifying the course of multiple sclerosis].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
120 (8) (2020)
M V Zhuravleva
,
A B Prokofiev
,
S Yu Serebrova
,
N S Vasyukova
,
E Yu Demchenkova
,
V V Arkhipov
[Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
120 (6) (2020)
V N Drozdov
,
A A Astapovskiy
,
S Yu Serebrova
,
N B Lazareva
,
Evgenia V Shikh
[Clinical efficacy of probiotic strains of the Bifidobacterium and Lactobacillus].
Voprosy pitaniia
89 (2) (2020)
M V Zhuravleva
,
A B Prokofiev
,
V V Arkhipov
,
S Yu Serebrova
,
G I Gorodetskay
,
O A Demidova
[The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
120 (3) (2020)